GlassScriptPhysician profile
Robert Gordon Henry
NPI 1184110876
$2,716.26
in general payments reported to CMS, 2019-2025
10 companies · $242 in 2025
The $242 reported for 2025 was more than what 79% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $742 · 2020: $61.77 · 2021: $96.14 · 2022: $33.56 · 2023: $1,324 · 2024: $216 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,495 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,494.83 |
| Education | $287.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,107.02 | 2021-2025 | Waveone Gold Conform Fit |
| Zimvie INC. | $502.51 | 2023-2025 | |
| Straumann USA LLC | $442.74 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $258.20 | 2019-2020 | |
| Tulsa Dental Products LLC | $103.29 | 2019 | |
| Biohorizons Implant Systems INC. | $75.85 | 2021-2022 | |
| Align Technology, INC. | $72.35 | 2023-2025 | Itero Element 5d Plus, Itero Element Flex, Invisalign |
| Henry Schein, INC. | $68.44 | 2024-2025 | Smartmatic S20, Multiflex Coupling 457, Kavo Prophypearls Neutral (4x 1 Fl.) |
| Ormco Corporation | $42.93 | 2023 | Kavo Op300 |
| Nobel Biocare USA | $42.93 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.